BRONCHIAL ASTHMA

This study tests a new inhaled medicine called PA9159 for adults with asthma. The goal is to see if it safely improves lung function over 4 weeks. About 30 participants will use the inhaler and have their breathing measured. It is a phase 2 trial, meaning it is still in early tes…

This study tests a new inhaled corticosteroid called PA9159 for adults with bronchial asthma. The goal is to see if it safely improves lung function over 4 weeks. About 60 participants will take the drug and have their breathing measured. This is a Phase 2 trial, meaning it's sti…

This study follows 40 children aged 6 to 14 with severe asthma that doesn't improve with standard treatments. They receive Fasenra injections to see how safe the drug is and how well it controls asthma symptoms. The goal is to manage the disease, not cure it.

This study tests whether a community-based exercise program can improve exercise capacity in 200 adults aged 18-85 with reduced heart or lung function. Participants will do 40-60 minutes of exercise (like brisk walking or cycling) five times a week for eight weeks. Researchers wi…

This study is collecting exhaled breath from 450 people with asthma, cystic fibrosis, and healthy volunteers. Researchers will analyze the breath for unique protein patterns that could signal lung inflammation or infection. The goal is to develop a simple, non-invasive breath tes…

This study looks at why many people with COPD and asthma do not use their inhalers correctly, and tests new ways to help them stick to their treatment. Researchers will work with 1,000 patients and their healthcare providers to measure adherence and improve inhalation techniques …